These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9063009)
1. A case report of extensive vitiligo. Wee TA Hawaii Med J; 1997 Feb; 56(2):37-40. PubMed ID: 9063009 [No Abstract] [Full Text] [Related]
2. Vitiligo. Dunn JF Am Fam Physician; 1986 May; 33(5):137-43. PubMed ID: 3706094 [TBL] [Abstract][Full Text] [Related]
3. New and experimental treatments of vitiligo and other hypomelanoses. Lotti T; Prignano F; Buggiani G Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905 [TBL] [Abstract][Full Text] [Related]
4. Vitiligo. Punshi SK Q Med Rev; 1979 Oct; 30(4):1-46. PubMed ID: 396546 [No Abstract] [Full Text] [Related]
5. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Fitzpatrick TB; Arndt KA; el-Mofty AM; Pathak MA Arch Dermatol; 1966 May; 93(5):589-600. PubMed ID: 5940924 [No Abstract] [Full Text] [Related]
6. [Current points of view on the therapy of vitiligo]. Ormea F Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771 [No Abstract] [Full Text] [Related]
7. [Vitiligo and ultraviolet exposure]. Hönigsmann H Dtsch Med Wochenschr; 1990 Sep; 115(37):1414. PubMed ID: 2401193 [No Abstract] [Full Text] [Related]
8. Should vitiligo be treated? Grimes PE; Kenney JA Cutis; 1983 Oct; 32(4):343-4, 346. PubMed ID: 6354615 [TBL] [Abstract][Full Text] [Related]
10. Focus Theme Issue: "Vitiligo and other pigmentary disorders". Picardo M; Taïeb A Exp Dermatol; 2019 Jun; 28(6):639-641. PubMed ID: 31215722 [No Abstract] [Full Text] [Related]
11. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. Elgoweini M; Nour El Din N J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407 [TBL] [Abstract][Full Text] [Related]
13. Tissue-engineered skin in the treatment of vitiligo lesions. Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161 [TBL] [Abstract][Full Text] [Related]
14. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Vanscheidt W; Hunziker T Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603 [TBL] [Abstract][Full Text] [Related]
15. Discussion of a case of vitiligo. Lerner MR; Fitzpatrick TB; Halder RM; Hawk JL Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):41-4. PubMed ID: 9990671 [No Abstract] [Full Text] [Related]
16. Vitiligo--treatment with trimethylpsoralen. Bleehen SS Br J Dermatol; 1971 Feb; 84(2):186-8. PubMed ID: 5548475 [No Abstract] [Full Text] [Related]
17. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo. Zailaie MZ Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818 [TBL] [Abstract][Full Text] [Related]
18. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666 [TBL] [Abstract][Full Text] [Related]